Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Eur Heart J
; 36(33): 2228-38, 2015 Sep 01.
Article
en En
| MEDLINE
| ID: mdl-26056125
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Terapia Genética
/
Isquemia Miocárdica
/
Quimiocina CXCL12
/
Insuficiencia Cardíaca
Tipo de estudio:
Clinical_trials
/
Guideline
/
Qualitative_research
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2015
Tipo del documento:
Article